The FDA Office of Regulatory Affairs advances public health by ensuring the safety, efficacy, and quality of regulated products through science-driven oversight and enforcement. Its core mission centers on supporting regulatory decision-making with advanced analytical capabilities, diagnostic tools,...
The FDA Office of Regulatory Affairs advances public health by ensuring the safety, efficacy, and quality of regulated products through science-driven oversight and enforcement. Its core mission centers on supporting regulatory decision-making with advanced analytical capabilities, diagnostic tools, and forensic capabilities. Strategic priorities include modernizing laboratory infrastructure, enhancing product surveillance systems, and strengthening compliance monitoring—particularly in areas such as medical devices, in-vitro diagnostics, and forensic testing. The agency actively invests in technologies that enable real-time product tracking, laboratory accreditation, and international regulatory alignment, with a focus on securing the integrity of the U.S. food, drug, and medical device supply chains.
Procurement patterns reveal a strong reliance on high-precision analytical instrumentation, specialized diagnostic substances, and technical services that support regulatory science. The agency frequently seeks laboratory equipment, software for monitoring regulated products, and consulting services to enhance operational efficiency and compliance workflows. Contract structures typically include sole-source, brand-name-or-equal, and combined solicitation vehicles, often leveraging government-wide acquisition contracts and indefinite-delivery/indefinite-quantity mechanisms to ensure rapid deployment of mission-critical capabilities.
Industry preferences are dominated by manufacturers of analytical laboratory instruments and in-vitro diagnostic substances, alongside providers of computer systems design, professional scientific services, and specialized training. The agency demonstrates a clear preference for Small Business Administration set-asides, particularly for software licensing, forensic services, and technical consulting, while also occasionally targeting Women-Owned Small Business contracts for human resources and language support services. Vendor relationships are built on technical expertise, regulatory familiarity, and proven compliance with federal quality standards.
Organized under the Food and Drug Administration within the Department of Health and Human Services, the Office of Regulatory Affairs operates nationwide with a decentralized field presence supporting inspections, investigations, and compliance activities. It employs a mix of direct procurement, interagency agreements, and cooperative contracts to fulfill its regulatory enforcement mandate across diverse geographic and scientific domains.
